Concurrent platinum (CDDP)-etoposide (VP-16) chemotherapy plus thoracic radiotherapy (TRT) for limited stage small cell lung cancer (SCLC) : N. Saijo, M. Fukuoka, K. Furuse, Y. Ariyoshi, Y. Nishiwaki, H. Ikegami, M. Oritsu A Japanese Lung Cancer Chemotherapy Group (JLCCG) study, ...
Cisplatinum (CDDP) and etoposide (VP16) in "poor risk" small cell lung carcinoma (SCLCA) - European Journal of Cancerdoi:10.1016/0959-8049(93)91496-8Casadio, M.Marioni, A.Melotti, B.Ramini, R.Pannuti, F.European Journal of Cancer...
尿路上皮癌に対するVP-16,CDDP,MTX併用療法の治療成績 : 第58回東部総会 来自 Semantic Scholar 喜欢 0 阅读量: 32 作者: 中内,憲二,吉田,正林,町田,豊平,大石,幸彦,浅野,晃司 年份: 1994 收藏 引用 批量引用 报错 分享 全部来源 求助全文 Semantic Scholar ...
Results of Cisplatin (CDDP)/Etoposide (VP16)/5-FU and alternatively Adriamycin or Mitomycin C (PEFAM) combination in primary resistant breast cancer and in heavily pre-treated metastatic breast cancerIn spite of the activity of chemotherapeutic agents, metastatic breast cancer remains an incurable ...
Prognosis of intracranial germ-cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 1993; 120: 111-7.Yoshida J, Sugita K, Kobayashi T, et al. Prognosis of in- tracranial germ cell tumours: effectiveness of chemotherapy with cisplatin...
Clinical evaluation of adjuvant chemoradiotherapy with CDDP, 5-Fu, and VP-16 for advanced esophageal cancer[J] . Hidenori Mukaida,Toshihiro Hirai,Yoshinori Yamashita,Kazuhiro Yoshida,Jun Hihara,Masaki Kuwahara,Hideki Inoue,Tetsuya Toge.The Japanese Journal of Thoracic and Cardiovascular Surgery . 1998 ...
应用Navelbine(NVB)与Cis-platinum(CDDP)组合,进行对肺腺癌治疗的临床观察,并与临床常用方案Etoposide(VP-16)Cis-platinum(CDDP)对照观察如下.1 材料与方法1 1 病例选择全部病例106例,随机分为A,B两组,各53例.条件为:1)非手术肺腺癌患者;2)有病理/细胞学及X线(CT,MRI)诊断;3)无重度心,肝,肾及骨髓功能...
Response rate in advanced soft tissue sarcoma using cisplatin (CDDP), adriamycin, and VP16An abstract is unavailable. This article is available as a PDF only.doi:10.1097/00043426-199123000-00031E. G. AntoneliR. MelaragnoL. A. Marques
Accelerated hyperfractionated thoracic radiation therapy plus concomitant VP16-CDDP chemotherapy for unresectable stage III non-small cell lung cancerShaw, E. G.McGinnis, W.Jett, J.Su, J.LUNG CANCER -AMSTERDAM-
CDDP-resistant (SBC-3/CDDP) and VP16-resistant (SBC-3/VP16) small cell lung cancer(SCLC) cells show a unique collateral sensitivity in culture : Taisuke OHNOSHI, Hiroshi UEOKA, Katsuyuki KIURA, Nagio TAKIGAWA and Ikuro KIMURA Department of Medicine, Okayama University Medical School, Okayama...